Kiniksa Pharmaceuticals International, plc

Ownership Transactions Reported by 15 Insiders

Symbol
KNSA on Nasdaq
Location
23 Old Bond Street, Floor 3, London, United Kingdom

Insiders trading volume in the past year

Kiniksa Pharmaceuticals International, plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director $70.5M Jun 3, 2025
Sanj K. Patel CHAIRMAN & CEO, Director $9.84M -$12.7M -56.4% Nov 12, 2025
Thomas Malley Director $2.82M -$5.86M -67.5% Aug 12, 2025
John F. Paolini Chief Medical Officer $2.63M -$4.03M -60.5% Oct 31, 2025
Mark Ragosa Chief Financial Officer $1.54M -$6.88M -81.7% Nov 12, 2025
Eben Tessari Chief Operating Officer $1.44M -$16.9M -92.1% Oct 14, 2025
Michael R. Megna Chief Accounting Officer $1.06M -$4.2M -79.8% Oct 20, 2025
Ross Moat Chief Corp. & Comm. Officer $684K -$3.84M -84.9% Sep 4, 2025
Tracey L. McCain Director $489K Jun 3, 2025
G. Bradley Cole Director $489K Jun 3, 2025
Richard S. Levy Director $473K Jul 1, 2025
Barry D. Quart Director $381K -$833K -68.6% Jun 9, 2025
Kimberly J. Popovits Director $375K Jul 30, 2025
Meta Cantey Boyd Director Oct 4, 2024
Arian Pano Chief Clinical Dev. Officer Sep 2, 2021

Recent Insider Transactions by Companies or Individuals for Kiniksa Pharmaceuticals International, plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.